- Home
- TRIB vs MIRA Comparison
TRIB vs MIRA Comparison
Compare TRIB & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- MIRA
- Stock Information
- Founded
- TRIB 1992
- MIRA 2020
- Country
- TRIB Ireland
- MIRA United States
- Employees
- TRIB N/A
- MIRA N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- TRIB Health Care
- MIRA Health Care
- Exchange
- TRIB Nasdaq
- MIRA Nasdaq
- Market Cap
- TRIB 25.5M
- MIRA 20.5M
- IPO Year
- TRIB N/A
- MIRA 2023
- Fundamental
- Price
- TRIB $0.59
- MIRA $0.95
- Analyst Decision
- TRIB
- MIRA Strong Buy
- Analyst Count
- TRIB 0
- MIRA 2
- Target Price
- TRIB N/A
- MIRA $14.00
- AVG Volume (30 Days)
- TRIB 37.2K
- MIRA 360.9K
- Earning Date
- TRIB 05-22-2025
- MIRA 05-12-2025
- Dividend Yield
- TRIB N/A
- MIRA N/A
- EPS Growth
- TRIB N/A
- MIRA N/A
- EPS
- TRIB N/A
- MIRA N/A
- Revenue
- TRIB $59,126,000.00
- MIRA N/A
- Revenue This Year
- TRIB $11.63
- MIRA N/A
- Revenue Next Year
- TRIB $10.13
- MIRA N/A
- P/E Ratio
- TRIB N/A
- MIRA N/A
- Revenue Growth
- TRIB N/A
- MIRA N/A
- 52 Week Low
- TRIB $0.56
- MIRA $0.51
- 52 Week High
- TRIB $3.55
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- TRIB 36.73
- MIRA 38.16
- Support Level
- TRIB $0.56
- MIRA $1.06
- Resistance Level
- TRIB $0.71
- MIRA $1.29
- Average True Range (ATR)
- TRIB 0.04
- MIRA 0.11
- MACD
- TRIB -0.01
- MIRA -0.02
- Stochastic Oscillator
- TRIB 15.62
- MIRA 4.74
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.